Prevalence and complication of COVID-19 in patients with ankylosing spondylitis (AS) and its relationship with TNF-a inhibitors.

Immunity, inflammation and disease（2023）

引用 0|浏览0

暂无评分

摘要

The use of the TNF-α inhibitors in patients with AS, may be associated with reduced hospitalization and death rate in COVID-19 cases.

查看译文

关键词

ankylosing spondylitis, biological drugs, COVID-19, outcomes

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要